HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Ependymoma is a rare type of brain or spinal cord tumor that primarily affects the ependymal cells lining the fluid-filled spaces in the central nervous system. These tumors can occur in both children and adults, although they are more commonly diagnosed in young children. Ependymomas can arise in various regions of the brain, including the fourth ventricle, the spinal cord, and the cerebral hemispheres. The exact cause of ependymomas is not well understood, and research is ongoing to unravel the underlying factors contributing to their development. Symptoms may vary depending on the tumor's location and can include headaches, nausea, vomiting, and changes in neurological function. Diagnosis often involves a combination of imaging studies such as MRI or CT scans, along with a biopsy to confirm the presence of ependymoma. Treatment typically involves surgical removal of the tumor, followed by radiation therapy to target any remaining cancer cells. Chemotherapy may also be considered in certain cases. Prognosis for individuals with ependymoma varies based on factors such as tumor location, grade, and the extent of surgical resection. Early detection and comprehensive treatment planning are crucial for optimizing outcomes. Long-term follow-up care is essential to monitor for potential recurrence and manage any late effects of treatment. Supportive care, including physical therapy and rehabilitation, may be recommended to address potential neurological deficits resulting from the tumor or its treatment. Multidisciplinary collaboration involving neurosurgeons, oncologists, and other specialists is key to providing comprehensive and personalized care for individuals affected by ependymoma.
